Search Results - "Wolfe, Jonathan T"

Refine Results
  1. 1

    Cutaneous metastatic breast carcinoma with clear cell features by Shinohara, Michi M., Tozbikian, Gary, Wolfe, Jonathan T., Shin, Sandra J., Mies, Carolyn, Elenitsas, Rosalie

    Published in Journal of cutaneous pathology (01-08-2013)
    “…Breast carcinoma remains one of the most common sources of skin metastases in women. Cutaneous breast carcinoma metastases have variable clinical and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Th2 Cytokine mRNA Expression in Skin in Cutaneous T-Cell Lymphoma by Vowels, Benjamin R, Lessin, Stuart R, Cassin, Maureen, Jaworsky, Christine, Benoit, Bernice, Wolfe, Jonathan T, Rook, Alain H

    Published in Journal of investigative dermatology (01-11-1994)
    “…We have previously demonstrated that peripheral blood mononuclear cells from patients with Sézary syndrome, the leukemic form of cutaneous T-cell lymphoma…”
    Get full text
    Journal Article
  4. 4

    Progression-related expression of β3 integrin in melanomas and nevi by Van Belle, Patricia A, Elenitsas, Rosalie, Satyamoorthy, Kapaettu, Wolfe, Jonathan T, Guerry, Dupont, Schuchter, Lynne, Van Belle, Timothy J, Albelda, Stephen, Tahin, Paulo, Herlyn, Meenhard, Elder, David E

    Published in Human pathology (1999)
    “…The expression of the β 3 integrin subunit was investigated in 130 fixed, paraffin-embedded specimens of human melanomas and nevi using two different…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The role of screening in the management of skin cancer by Wolfe, Jonathan T

    Published in Current opinion in oncology (01-03-1999)
    “…The incidence of skin cancer has been rising at an alarming rate for the past several years. This poses a significant public health problem in the United…”
    Get full text
    Journal Article
  7. 7

    Prevention and early detection of malignant melanoma by Edman, R L, Wolfe, J T

    Published in American family physician (15-11-2000)
    “…In addressing the problem of malignant melanoma, family physicians should emphasize primary prevention. This includes educating patients about the importance…”
    Get full text
    Journal Article
  8. 8

    Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution by Suchin, Karen Rebecca, Cucchiara, Andrew J, Gottleib, Scott L, Wolfe, Jonathan T, DeNardo, Barbara J, Macey, William H, Bromley, Patricia G, Vittorio, Carmela C, Rook, Alain H

    Published in Archives of dermatology (1960) (01-08-2002)
    “…To determine the efficacy of multimodality biologic response therapy for patients with cutaneous T-cell lymphoma (CTCL). Retrospective cohort study over a…”
    Get more information
    Journal Article
  9. 9

    De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma by Wolfe, Jonathan T, Singh, Anjali, Lessin, Stuart R, Jaworsky, Christine, Rook, Alain H

    “…Presumably because of its potent immunomodulatory activity, the use of interferon has led to the development of autoimmune disease in susceptible individuals…”
    Get full text
    Journal Article
  10. 10

    Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells by Krueger, J G, Wolfe, J T, Nabeya, R T, Vallat, V P, Gilleaudeau, P, Heftler, N S, Austin, L M, Gottlieb, A B

    Published in The Journal of experimental medicine (01-12-1995)
    “…Skin irradiation with ultraviolet B (UVB) is a common and often durable treatment for psoriasis and other inflammatory skin disorders. We studied the effects…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Information from your family doctor: How to prevent melanoma by Edman, Richard L, Wolfe, Jonathan T

    Published in American family physician (15-11-2000)
    “…Melanoma is becoming more common every year, and this is a very serious kind of skin cancer than can cause death. If this cancer is caught early, when it is…”
    Get full text
    Journal Article
  13. 13

    IL-12 reverses cytokine and immune abnormalities in Sezary syndrome by Rook, AH, Kubin, M, Cassin, M, Vonderheid, EC, Vowels, BR, Wolfe, JT, Wolf, SF, Singh, A, Trinchieri, G, Lessin, SR

    Published in The Journal of immunology (1950) (01-02-1995)
    “…Cutaneous T cell lymphoma is a lymphoproliferative disorder typically characterized by skin invasion of clonally derived malignant CD4+ lymphocytes that…”
    Get full text
    Journal Article
  14. 14

    Overexpression of p53 Protein in Cutaneous T Cell Lymphoma: Relationship to Large Cell Transformation and Disease Progression by Li, Guoqing, Chooback, Lilian, Wolfe, Jonathan T., Rook, Alain H., Felix, Carolyn A., Lessin, Stuart R., Salhany, Kevin E.

    Published in Journal of investigative dermatology (01-05-1998)
    “…The molecular mechanisms by which advanced cases of cutaneous T cell lymphoma (CTCL) (mycosis fungoides/Sezary syndrome) undergo large cell transformation…”
    Get full text
    Journal Article
  15. 15

    Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients by Rook, A H, Jaworsky, C, Nguyen, T, Grossman, R A, Wolfe, J T, Witmer, W K, Kligman, A M

    Published in Transplantation (15-03-1995)
    “…Renal transplant recipients experience a greatly increased frequency of neoplastic skin lesions, including aggressive squamous cell carcinomas. Recent reports…”
    Get more information
    Journal Article
  16. 16

    Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor by Wolfe, J T, Chooback, L, Finn, D T, Jaworsky, C, Rook, A H, Lessin, S R

    Published in Journal of clinical oncology (01-07-1995)
    “…One of the unique characteristics of cutaneous T-cell lymphoma (CTCL) is its ability to undergo cytologic transformation in which the malignant T cells develop…”
    Get more information
    Journal Article
  17. 17

    Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection by Wolfe, J T, Lessin, S R, Singh, A H, Rook, A H

    Published in Artificial organs (01-12-1994)
    “…Photopheresis is an apheresis-based therapy that is currently available at approximately 70 medical centers worldwide. Recent evidence indicates that…”
    Get more information
    Journal Article
  18. 18

    Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature by Weinberg, J M, Wolfe, J T, Sood, S, Saruk, M, Rook, A H, Spiers, E M

    Published in Acta dermato-venereologica (01-03-1997)
    “…Interferons are cytokines produced by cells in response to stimulation by certain antigens and infectious agents. In recent years, recombinant interferons have…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Reversal of acute renal allograft rejection by extracorporeal photopheresis: A case presentation and review of the literature by Wolfe, Jonathan T., Tomaszewski, John E., Grossman, Robert A., Gottlieb, Scott L., Naji, Ali, Brayman, Kenneth L., Kobrin, Sydney M., Rook, Alain H.

    Published in Journal of clinical apheresis (1996)
    “…There is a clear need for well‐tolerated immunomodulatory agents that can aid in the prevention of acute solid organ rejection. Extracorporeal photopheresis is…”
    Get full text
    Journal Article